Dr. Jordan Berlin, MD
Claim this profileVanderbilt-Ingram Cancer Center
Studies Colorectal Cancer
Studies Solid Tumors
13 reported clinical trials
21 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
RET positive
Stage III
2Solid Tumors
Stage IV
HER2 positive
Stage III
Affiliated Hospitals
Clinical Trials Jordan Berlin, MD is currently running
BMS-986340 + Nivolumab/Docetaxel
for Cancer
This trial tests a new drug, BMS-986340, alone and with other cancer treatments (nivolumab and docetaxel) in patients with advanced solid tumors. The goal is to find out if it is safe and effective in treating these cancers.
Recruiting1 award Phase 1 & 26 criteria
TOS-358
for Cancer
This trial tests TOS-358, a new drug for adults with specific cancers that have a genetic mutation. It aims to find the safest dose and see how well patients tolerate it. The drug works by blocking a gene that helps cancer cells grow.
Recruiting1 award Phase 1
More about Jordan Berlin, MD
Clinical Trial Related7 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Jordan Berlin, MD has experience with
- Nivolumab
- Docetaxel
- SM08502
- Ipilimumab
- Rivoceranib
- Trifluridine/Tipiracil
Breakdown of trials Jordan Berlin, MD has run
Colorectal Cancer
Solid Tumors
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jordan Berlin, MD specialize in?
Jordan Berlin, MD focuses on Colorectal Cancer and Solid Tumors. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are RET positive.
Is Jordan Berlin, MD currently recruiting for clinical trials?
Yes, Jordan Berlin, MD is currently recruiting for 6 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Jordan Berlin, MD has studied deeply?
Yes, Jordan Berlin, MD has studied treatments such as Nivolumab, Docetaxel, SM08502.
What is the best way to schedule an appointment with Jordan Berlin, MD?
Apply for one of the trials that Jordan Berlin, MD is conducting.
What is the office address of Jordan Berlin, MD?
The office of Jordan Berlin, MD is located at: Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt-Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.